Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012, Article ID 134636, 4 pages
http://dx.doi.org/10.1155/2012/134636
Case Report

Early Bilateral Cystoid Macular Oedema Secondary to Fingolimod in Multiple Sclerosis

Department of Ophthalmology, Royal United Hospital Bath, Bath BA1 3NG, UK

Received 1 July 2012; Accepted 3 September 2012

Academic Editor: Marco A. Zarbin

Copyright © 2012 Lei Liu and Fiona Cuthbertson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Heather Gwen Mack, Melissa Chih-Hui Tien, and Owen Bruce White, “Acute Anterior Uveitis in a Patient Taking Fingolimod (FTY720) for Multiple Sclerosis.,” Case reports in ophthalmology, vol. 7, no. 3, pp. 284–288, . View at Publisher · View at Google Scholar
  • Ilias Georgalas, Constantine D. Georgakopoulos, and Olga E. Makri, “Drug-Induced Macular Edema,” Drugs, vol. 73, no. 8, pp. 789–802, 2013. View at Publisher · View at Google Scholar
  • Vivien Li, Jack Kane, Helen H L Chan, Anthony J Hall, and Helmut Butzkueven, “Continuing fingolimod after development of macular edema: A case report.,” Neurology(R) neuroimmunology & neuroinflammation, vol. 1, no. 2, 2014. View at Publisher · View at Google Scholar
  • Yan Zhang, Yujing Bi, Hui Yang, Xi Chen, Huanrong Liu, Yun Lu, Zhengguo Zhang, Jiongbo Liao, Shan Yang, Yiwei Chu, Ruifu Yang, and Guangwei Liu, “mTOR limits the recruitment of CD11b(+)Gr1(+)Ly6C(high) myeloid-derived suppressor cells in protecting against murine immunological hepatic injury,” Journal of Leukocyte Biology, vol. 95, no. 6, pp. 961–970, 2014. View at Publisher · View at Google Scholar
  • Simon A. Broadley, Michael H. Barnett, Mike Boggild, Bruce J. Brew, Helmut Butzkueven, Robert Heard, Suzanne Hodgkinson, Allan G. Kermode, Jeannette Lechner-Scott, Richard A. L. Macdonell, Mark Marriott, Deborah F. Mason, John Parratt, Stephen W. Reddel, Cameron P. Shaw, Mark Slee, Judith Spies, Bruce V. Taylor, William M. Carroll, Trevor J. Kilpatrick, John King, Pamela A. McCombe, John D. Pollard, and Ernest Willoughby, “Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations,” Journal of Clinical Neuroscience, vol. 21, no. 11, pp. 1857–1865, 2014. View at Publisher · View at Google Scholar
  • Angelina Espino Barros Palau, Michael L. Morgan, Sushma Yalamanchili, and Andrew G. Lee, “Neuro-Ophthalmology Annual Review,” Asia-Pacific Journal of Ophthalmology, vol. 3, no. 2, pp. 104–125, 2014. View at Publisher · View at Google Scholar
  • Elizabeth Park, Naomi R. Goldberg, and Sylvia Adams, “Nab-paclitaxel-induced cystoid macular edema in a patient with pre-existing optic neuropathy,” Anti-Cancer Drugs, vol. 27, no. 6, pp. 580–584, 2016. View at Publisher · View at Google Scholar
  • Torsten Schlote, and Ulrich Kellner, “Adverse Drug Reactions in Ophthalmology - Update 2015/2016,” Klinische Monatsblatter fur Augenheilkunde, vol. 233, no. 2, pp. 203–219, 2016. View at Publisher · View at Google Scholar
  • Refik Pul, Alma Osmanovic, Holger Schmalstieg, Amelie Pielen, Kaweh Pars, Philipp Schwenkenbecher, Kurt Sühs, Özlem Yildiz, Benedikt Frank, Martin Stangel, and Thomas Skripuletz, “Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?,” International Journal of Molecular Sciences, vol. 17, no. 12, pp. 2106, 2016. View at Publisher · View at Google Scholar
  • P Mandal, A Gupta, W Fusi-Rubiano, P A Keane, and Y Yang, “Fingolimod: therapeutic mechanisms and ocular adverse effects.,” Eye (London, England), vol. 31, no. 2, pp. 232–240, 2017. View at Publisher · View at Google Scholar
  • Yara Dadalti Fragoso, “Multiple sclerosis treatment with fingolimod: profile of non-cardiologic adverse events,” Acta Neurologica Belgica, vol. 117, no. 4, pp. 821–827, 2017. View at Publisher · View at Google Scholar